|
1
|
Riggs M, Franklin R and Saylany L:
Associations between cardiopulmonary resuscitation (CPR) knowledge,
self-efficacy, training history and willingness to perform CPR and
CPR psychomotor skills: A systematic review. Resuscitation.
138:259–272. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang Z, Zhai ZG, Liang LR, Liu FF, Yang
YH and Wang C: Lower dosage of recombinant tissue-type plasminogen
activator (rt-PA) in the treatment of acute pulmonary embolism: A
systematic review and meta-analysis. Thromb Res. 133:357–363. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Monsieurs KG, Nolan JP, Bossaert LL, Greif
R, Maconochie IK, Nikolaou NI, Perkins GD, Soar J, Truhlář A,
Wyllie J, et al: European resuscitation council guidelines for
resuscitation 2015: Section 1. Executive summary. Resuscitation.
95:1–80. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Taffet GE, Teasdale TA and Luchi RJ:
In-hospital cardiopulmonary resuscitation. JAMA. 260:2069–2072.
1988. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kamali MJ, Salehi M and Fath MK: Advancing
personalized immunotherapy for melanoma: Integrating
immunoinformatics in multi-epitope vaccine development, neoantigen
identification via NGS, and immune simulation evaluation. Comput
Biol Med. 188:1098852025. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Konstantinides SV, Meyer G, Becattini C,
Bueno H, Geersing GJ, Harjola VP, Huisman MV, Humbert M, Jennings
CS, Jiménez D, et al: 2019 ESC guidelines for the diagnosis and
management of acute pulmonary embolism developed in collaboration
with the European respiratory society (ERS) the task force for the
diagnosis and management of acute pulmonary embolism of the
European Society of Cardiology (ESC). Eur Heart J. 41:543–603.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gilbert CR, Wilshire CL, Chang SC and
Gorden JA: The use of intrapleural thrombolytic or fibrinolytic
therapy, or both, via indwelling tunneled pleural catheters with or
without concurrent anticoagulation use. Chest. 160:776–783. 2021.
View Article : Google Scholar
|
|
8
|
Ortel TL, Neumann I, Ageno W, Beyth R,
Clark NP, Cuker A, Hutten BA, Jaff MR, Manja V, Schulman S, et al:
American Society of Hematology 2020 guidelines for management of
venous thromboembolism: Treatment of deep vein thrombosis and
pulmonary embolism. Blood Adv. 4:4693–4738. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Altaf F, Wu S and Kasim V: Role of
fibrinolytic enzymes in anti-thrombosis therapy. Front Mol Biosci.
8:6803972021. View Article : Google Scholar
|
|
10
|
Grines CL, Serruys P and O'Neill WW:
Fibrinolytic therapy: Is it a treatment of the past? Circulation.
107:2538–2542. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang S, Wang D and Li L: Recombinant
tissue-type plasminogen activator (rt-PA) effectively restores
neurological function and improves prognosis in acute ischemic
stroke. Am J Transl Res. 15:34602023.PubMed/NCBI
|
|
12
|
Leal Rato M, Diógenes MJ and Sebastião A:
Pharmacodynamics and pharmacokinetics of stroke therapy. Precision
Medicine in Stroke. Springer Nature; pp. 41–69. 2021, View Article : Google Scholar
|
|
13
|
Marko M, Posekany A, Szabo S, Scharer S,
Kiechl S, Knoflach M, Serles W, Ferrari J, Lang W, Sommer P, et al:
Trends of r-tPA (recombinant tissue-type plasminogen activator)
treatment and treatment-influencing factors in acute ischemic
stroke. Stroke. 51:1240–1247. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Llucià-Carol L, Muiño E, Gallego-Fabrega
C, Cárcel-Márquez J, Martín-Campos J, Lledós M, Cullell N and
Fernández-Cadenas I: Pharmacogenetics studies in stroke patients
treated with rtPA: A review of the most interesting findings.
Pharmacogenomics. 22:1091–1097. 2021. View Article : Google Scholar
|
|
15
|
Peppard SR, Parks AM and Zimmerman J:
Characterization of alteplase therapy for presumed or confirmed
pulmonary embolism during cardiac arrest. Am J Health Syst Pharm.
75:870–875. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kotb E: The biotechnological potential of
fibrinolytic enzymes in the dissolution of endogenous blood
thrombi. Biotechnol Prog. 30:656–672. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sharifi M, Berger J, Beeston P, Bay C,
Vajo Z and Javadpoor S; ‘PEAPETT’ investigators, : Pulseless
electrical activity in pulmonary embolism treated with thrombolysis
(from the ‘PEAPETT’ study). Am J Emerg Med. 34:1963–1967. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dejouvencel T, Doeuvre L, Lacroix R,
Plawinski L, Dignat-George F, Lijnen HR and Anglés-Cano E:
Fibrinolytic cross-talk: A new mechanism for plasmin formation.
Blood. 115:2048–2056. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Böttiger BW, Bode C, Kern S, Gries A, Gust
R, Glätzer R, Bauer H, Motsch J and Martin E: Efficacy and safety
of thrombolytic therapy after initially unsuccessful
cardiopulmonary resuscitation: A prospective clinical trial.
Lancet. 357:1583–1585. 2001. View Article : Google Scholar
|
|
20
|
Iyer A, Zurolo E, Boer K, Baayen J,
Giangaspero F, Arcella A, Di Gennaro GC, Esposito V, Spliet WG, van
Rijen PC, et al: Tissue plasminogen activator and urokinase
plasminogen activator in human epileptogenic pathologies.
Neuroscience. 167:929–945. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Badimon L, Padró T and Vilahur G:
Atherosclerosis, platelets and thrombosis in acute ischaemic heart
disease. Eur Heart J Acute Cardiovasc Care. 1:60–74.
2012.PubMed/NCBI
|
|
22
|
Yepes M: The uPA/uPAR system in astrocytic
wound healing. Neural Regen Res. 17:2404–2406. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang B, Leung L, Su EJ and Lawrence DA:
PA system in the pathogenesis of ischemic stroke. Arterioscler
Thromb Vasc Biol. 45:600–608. 2025. View Article : Google Scholar
|
|
24
|
Kadir RRA and Bayraktutan U: Urokinase
plasminogen activator: A potential thrombolytic agent for ischaemic
stroke. Cell Mol Neurobiol. 40:347–355. 2020. View Article : Google Scholar
|
|
25
|
Emberson J, Lees KR, Lyden P, Blackwell L,
Albers G, Bluhmki E, Brott T, Cohen G, Davis S, Donnan G, et al:
Effect of treatment delay, age, and stroke severity on the effects
of intravenous thrombolysis with alteplase for acute ischaemic
stroke: A meta-analysis of individual patient data from randomised
trials. Lancet. 384:1929–1935. 2014. View Article : Google Scholar
|
|
26
|
Katsanos AH, Psychogios K, Turc G, Sacco
S, de Sousa DA, De Marchis GM, Palaiodimou L, Filippou DK, Ahmed N,
Sarraj A, et al: Off-label use of tenecteplase for the treatment of
acute ischemic stroke: A systematic review and meta-analysis. JAMA
Netw Open. 5:e2245062022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fredriksson L, Lawrence DA and Medcalf RL:
tPA modulation of the blood-brain barrier: A unifying explanation
for the pleiotropic effects of tPA in the CNS. Semin Thromb Hemost.
43:154–168. 2017.
|
|
28
|
Katz JM and Tadi P: Physiology,
plasminogen activation. StatPearls Publishing; Treasure Island:
2019
|
|
29
|
Gurman P, Miranda O, Nathan A, Washington
C, Rosen Y and Elman N: Recombinant tissue plasminogen activators
(rtPA): A review. Clin Pharmacol Ther. 97:274–285. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lederer W, Lichtenberger C, Pechlaner C,
Kroesen G and Baubin M: Recombinant tissue plasminogen activator
during cardiopulmonary resuscitation in 108 patients with
out-of-hospital cardiac arrest. Resuscitation. 50:71–76. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sabermoghadam R, Shahmahmood TM, Sarvghadi
P and Toosi MB: The gross, fine, and oral motor functions in a
patient with megalencephalic leukoencephalopathy with subcortical
cyst: A case report. Iran J Child Neurol. 17:149–161. 2023.
|
|
32
|
Hasanoğlu H, Hezer H, Karalezli A, Argüder
E, Kiliç H, Şentürk A, Er M and Soytürk AN: Half-dose recombinant
tissue plasminogen activator treatment in venous thromboembolism. J
Investig Med. 62:71–77. 2014. View Article : Google Scholar
|
|
33
|
Wang X, Li X, Xu Y, Li R, Yang Q, Zhao Y,
Wang F, Sheng B, Wang R, Chen S, et al: Effectiveness of
intravenous r-tPA versus UK for acute ischaemic stroke: A
nationwide prospective Chinese registry study. Stroke Vasc Neurol.
6:603–609. 2021. View Article : Google Scholar
|
|
34
|
Li BH, Wang JH, Wang H, Wang DZ, Yang S,
Guo FQ and Yu NW: Different doses of intravenous tissue-type
plasminogen activator for acute ischemic stroke: A network
meta-analysis. Front Neurol. 13:8842672022. View Article : Google Scholar
|
|
35
|
Amini S, Bakhshandeh H, Mosaed R, Abtahi
H, Sadeghi K and Mojtahedzadeh M: Efficacy and safety of different
dosage of recombinant tissue-type plasminogen activator (rt-PA) in
the treatment of acute pulmonary embolism: A systematic review and
meta-analysis. Iran J Pharm Res. 20:441–454. 2021.PubMed/NCBI
|
|
36
|
Bakkum MJ, Schouten VL, Smulders YM,
Nossent EJ, van Agtmael MA and Tuinman PR: Accelerated treatment
with rtPA for pulmonary embolism induced circulatory arrest. Thromb
Res. 203:74–80. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhong K, An X, Kong Y and Chen Z:
Predictive model for the risk of hemorrhagic transformation after
rt-PA intravenous thrombolysis in patients with acute ischemic
stroke: A systematic review and meta-analysis. Clin Neurol
Neurosurg. 239:1082252024. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hezer H, Kiliç H, Abuzaina O, Hasanoğlu HC
and Karalezli A: Long-term results of low-dose tissue plasminogen
activator therapy in acute pulmonary embolism. J Investig Med.
67:1142–1147. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ucar EY, Araz O, Kerget B, Yilmaz N, Akgun
M and Saglam L: Comparison of long-term outcomes of 50 and 100 mg
rt-PA in the management of acute pulmonary thromboembolism. Clin
Respir J. 12:1628–1634. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Salehi M, Kamali MJ, Ashuori Z, Ghadimi F,
Shafiee M, Babaei S and Moghadam AA: Functional significance of
tRNA-derived fragments in sustained proliferation of tumor cells.
Gene Rep. 35:1019012024. View Article : Google Scholar
|
|
41
|
Le Conte P, Huchet L, Trewick D, Longo C,
Vial I, Batard E, Yatim D, Touzé MD and Baron D: Efficacy of
alteplase thrombolysis for ED treatment of pulmonary embolism with
shock. Ame J Emerg Med. 21:438–440. 2003. View Article : Google Scholar
|
|
42
|
Cokkinos P: Post-resuscitation care:
Current therapeutic concepts. Acute Card Care. 11:131–137. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Herlitz J, Castren M, Friberg H, Nolan J,
Skrifvars M, Sunde K and Steen PA: Post resuscitation care: What
are the therapeutic alternatives and what do we know?
Resuscitation. 69:15–22. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Javaudin F, Lascarrou JB, Le Bastard Q,
Bourry Q, Latour C, De Carvalho H, Le Conte P, Escutnaire J, Hubert
H, Montassier E, et al: Thrombolysis during resuscitation for
out-of-hospital cardiac arrest caused by pulmonary embolism
increases 30-day survival: Findings from the French National
Cardiac Arrest Registry. Chest. 156:1167–1175. 2019. View Article : Google Scholar
|
|
45
|
Dasa O, Ruzieh M, Ammari Z, Syed MA,
Brickman KR and Gupta R: It's a ST-elevation myocardial infarction
(STEMI), or is it? Massive pulmonary embolism presenting as STEMI.
J Emerg Med. 55:125–127. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Villablanca PA, Vlismas PP, Aleksandrovich
T, Omondi A, Gupta T, Briceno DF, Garcia MJ and Wiley J: Case
report and systematic review of pulmonary embolism mimicking
ST-elevation myocardial infarction. Vascular. 27:90–97. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Fatovich DM, Dobb GJ and Clugston RA: A
pilot randomised trial of thrombolysis in cardiac arrest (The TICA
trial). Resuscitation. 61:309–313. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bozeman WP, Kleiner DM and Ferguson KL:
Empiric tenecteplase is associated with increased return of
spontaneous circulation and short term survival in cardiac arrest
patients unresponsive to standard interventions. Resuscitation.
69:399–406. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Janata K, Holzer M, Kürkciyan I, Losert H,
Riedmüller E, Pikula B, Laggner AN and Laczika K: Major bleeding
complications in cardiopulmonary resuscitation: The place of
thrombolytic therapy in cardiac arrest due to massive pulmonary
embolism. Resuscitation. 57:49–55. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Abu-Laban RB, Christenson JM, Innes GD,
van Beek CA, Wanger KP, McKnight RD, MacPhail IA, Puskaric J,
Sadowski RP, Singer J, et al: Tissue plasminogen activator in
cardiac arrest with pulseless electrical activity. N Engl J Med.
346:1522–1528. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Spöhr F, Arntz HR, Bluhmki E, Bode C,
Carli P, Chamberlain D, Danays T, Poth J, Skamira C, Wenzel V and
Böttiger BW: International multicentre trial protocol to assess the
efficacy and safety of tenecteplase during cardiopulmonary
resuscitation in patients with out-of-hospital cardiac arrest: The
thrombolysis in cardiac arrest (TROICA) study. Eur J Clin Invest.
35:315–323. 2005. View Article : Google Scholar
|
|
52
|
Doelare SA, Oukrich S, Ergin K, Jongkind
V, Wiersema AM, Lely RJ, Ebben HP, Yeung KK and Hoksbergen AWJ:
Collaborators: Major bleeding during thrombolytic therapy for acute
lower limb ischaemia: Value of laboratory tests for clinical
decision making, 17 years of experience. Eur J Vasc Endovasc Surg.
65:398–404. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Pereira R, Bowen M, Rapezzano G, Redpath
A, Pratt S and Hallowell G: Use of recombinant tissue plasminogen
activator (rTPA) for treatment of fibrin in the anterior chamber of
the horse. Vet Med Sci. 10:e14482024. View Article : Google Scholar
|
|
54
|
Vandebroek AC, Rickmann A, Boden KT, Seitz
B, Szurman P and Schulz A: Thrombolytic activity of recombinant
tissue-type plasminogen activator (rtPA) in in-vitro model for
subretinal hemorrhages. Int Ophthalmol. 45:1642025. View Article : Google Scholar
|
|
55
|
Li X, Chen Y, Dong Z, Zhang F, Chen P and
Zhang P: A study of the safety and efficacy of multi-mode
NMR-guided double-antiplatelet pretreatment combined with low-dose
rtPA in the treatment of acute mild ischemic stroke. Front Neurol.
16:14820782025. View Article : Google Scholar
|
|
56
|
Oh TK, Park YM, Do SH, Hwang JW and Song
IA: ROSC rates and live discharge rates after cardiopulmonary
resuscitation by different CPR teams-a retrospective cohort study.
BMC Anesthesiol. 17:1–9. 2017. View Article : Google Scholar
|
|
57
|
Gräsner JT, Wnent J, Herlitz J, Perkins
GD, Lefering R, Tjelmeland I, Koster RW, Masterson S, Rossell-Ortiz
F, Maurer H, et al: Survival after out-of-hospital cardiac arrest
in Europe-Results of the EuReCa TWO study. Resuscitation.
148:218–226. 2020. View Article : Google Scholar
|
|
58
|
Wang Y, Wang M, Ni Y, Liang B and Liang Z:
Can systemic thrombolysis improve prognosis of cardiac arrest
patients during cardiopulmonary resuscitation? A systematic review
and meta-analysis. J Emerg Med. 57:478–487. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Nolan JP, Soar J, Smith GB, Gwinnutt C,
Parrott F, Power S, Harrison DA, Nixon E and Rowan K; National
Cardiac Arrest Audit, : Incidence and outcome of in-hospital
cardiac arrest in the United Kingdom National Cardiac Arrest audit.
Resuscitation. 85:987–992. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Hoiland RL, Ainslie PN, Wellington CL,
Cooper J, Stukas S, Thiara S, Foster D, Fergusson NA, Conway EM,
Menon DK, et al: Brain hypoxia is associated with neuroglial injury
in humans post-cardiac arrest. Circ Res. 129:583–597. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Hoiland RL, Robba C, Menon DK, Citerio G,
Sandroni C and Sekhon MS: Clinical targeting of the cerebral oxygen
cascade to improve brain oxygenation in patients with
hypoxic-ischaemic brain injury after cardiac arrest. Intensive Care
Med. 49:1062–1078. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Panchal AR, Bartos JA, Cabañas JG, Donnino
MW, Drennan IR, Hirsch KG, Kudenchuk PJ, Kurz MC, Lavonas EJ,
Morley PT, et al: Part 3: Adult basic and advanced life support:
2020 American Heart Association guidelines for cardiopulmonary
resuscitation and emergency cardiovascular care. Circulation. 142
(16_Suppl_2):S366–S468. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Soar J, Böttiger BW, Carli P, Couper K,
Deakin CD, Djärv T, Lott C, Olasveengen T, Paal P, Pellis T, et al:
European resuscitation council guidelines 2021: Adult advanced life
support. Resuscitation. 161:115–151. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Stadlbauer KH, Krismer AC, Arntz HR, Mayr
VD, Lienhart HG, Böttiger BW, Jahn B, Lindner KH and Wenzel V:
Effects of thrombolysis during out-of-hospital cardiopulmonary
resuscitation. Am J Cardiol. 97:305–308. 2006. View Article : Google Scholar
|
|
65
|
Lott C, Truhlář A, Alfonzo A, Barelli A,
González-Salvado V, Hinkelbein J, Nolan JP, Paal P, Perkins GD,
Thies KC, et al: European resuscitation council guidelines 2021:
Cardiac arrest in special circumstances. Resuscitation.
161:152–219. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Page MJ, McKenzie JE, Bossuyt PM, Boutron
I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan
SE, et al: The PRISMA 2020 statement: An updated guideline for
reporting systematic reviews. BMJ. 372:n712021. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Higgins J, Altman DG, Gøtzsche PC, Jüni P,
Moher D, Oxman AD, Savović J, Schulz KF, Weeks L and SterneJA C;
Cochrane Bias Methods GroupCochrane Statistical Methods Group, :
The cochrane collaboration's tool for assessing risk of bias in
randomised trials. BMJ. 343:d59282011. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Blum B, Wormack L, Holtel M, Penwell A,
Lari S, Walker B and Nathaniel TI: Gender and thrombolysis therapy
in stroke patients with incidence of dyslipidemia. BMC Womens
Health. 19:112019. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Stang A: Critical evaluation of the
Newcastle-Ottawa scale for the assessment of the quality of
nonrandomized studies in meta-analyses. Eur J Epidemiol.
25:603–605. 2010. View Article : Google Scholar
|
|
70
|
Qiao Y, Wang J, Nguyen T, Liu L, Ji X and
Zhao W: Intravenous thrombolysis with urokinase for acute ischemic
stroke. Brain Sci. 14:9892024. View Article : Google Scholar
|
|
71
|
Broderick C, Watson L and Armon MP:
Thrombolytic strategies versus standard anticoagulation for acute
deep vein thrombosis of the lower limb. Cochrane Database Syst Rev.
1:CD0027832021.PubMed/NCBI
|
|
72
|
Kluft C, Sidelmann JJ and Gram JB:
Assessing safety of thrombolytic therapy. Semin Thromb Hemost.
43:300–310. 2017.
|
|
73
|
Renard A, Verret C, Jost D, Meynard JB,
Tricehreau J, Hersan O, Fontaine D, Briche F, Benner P, de
Stabenrath O, et al: Impact of fibrinolysis on immediate prognosis
of patients with out-of-hospital cardiac arrest. J Thromb
Thrombolysis. 32:405–409. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Wardlaw JM, Koumellis P and Liu M:
Thrombolysis (different doses, routes of administration and agents)
for acute ischaemic stroke. Cochrane Database Syst Rev.
31:CD0005142013.
|
|
75
|
Ramaswamy VV, Abiramalatha T, Weiner GM
and Trevisanuto D: A comparative evaluation and appraisal of 2020
American Heart Association and 2021 European Resuscitation Council
neonatal resuscitation guidelines. Resuscitation. 167:151–159.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Semeraro F, Greif R, Böttiger BW, Burkart
R, Cimpoesu D, Georgiou M, Yeung J, Lippert F, Lockey AS,
Olasveengen TM, et al: European resuscitation council guidelines
2021: Systems saving lives. Resuscitation. 161:80–97. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Nolan JP, Sandroni C, Böttiger BW, Cariou
A, Cronberg T, Friberg H, Genbrugge C, Haywood K, Lilja G, Moulaert
VRM, et al: European resuscitation council and European society of
intensive care medicine guidelines 2021: Post-resuscitation care.
Resuscitation. 161:220–269. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Yousuf T, Brinton T, Ahmed K, Iskander J,
Woznicka D, Kramer J, Kopiec A, Chadaga AR and Ortiz K: Tissue
plasminogen activator use in cardiac arrest secondary to fulminant
pulmonary embolism. J Clin Med Res. 8:190–195. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Sobala R, Kibbler J, Yip K, Thompson R,
Rafique C, Steward M, Samanta R; INSPIRE ERUPT collaborators, ; Jha
A, Rahman N and De Soyza A: Evaluation of Real-world use of
pulmonary embolism thrombolysis (ERUPT). ERJ Open Res.
11:00935–2024. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Nadkarni VM, Larkin GL, Peberdy MA, Carey
SM, Kaye W, Mancini ME, Nichol G, Lane-Truitt T, Potts J, Ornato
JP, et al: First documented rhythm and clinical outcome from
in-hospital cardiac arrest among children and adults. JAMA.
295:50–57. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Nolan J, Laver S, Welch C, Harrison D,
Gupta V and Rowan K: Outcome following admission to UK intensive
care units after cardiac arrest: A secondary analysis of the ICNARC
case mix programme database. Anaesthesia. 62:1207–1216. 2007.
View Article : Google Scholar
|
|
82
|
Miyazaki K, Hikone M, Kuwahara Y, Ishida
T, Sugiyama K and Hamabe Y: Extracorporeal CPR for massive
pulmonary embolism in a ‘hybrid 2136 emergency department’. Am J
Emerg Med. 37:2132–2135. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Wallentin L, Goldstein P, Armstrong PW,
Granger CB, Adgey AA, Arntz HR, Bogaerts K, Danays T, Lindahl B,
Makijarvi M, et al: Efficacy and safety of tenecteplase in
combination with the low-molecular-weight heparin enoxaparin or
unfractionated heparin in the prehospital setting: the assessment
of the safety and efficacy of a new thrombolytic regimen (ASSENT)-3
PLUS randomized trial in acute myocardial infarction. Circulation.
108:135–142. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Ali MR, Hossain MS, Islam MA, Arman MS,
Raju GS, Dasgupta P and Noshin TF: Aspect of thrombolytic therapy:
A review. ScientificWorldJournal. 2014:5865102014. View Article : Google Scholar
|
|
85
|
Saber-Moghadam R: Investigating the
efficacy of noninvasive brain stimulation on poststroke dysphagia:
A systematic review. JNFH. 10:P2862022.
|
|
86
|
Beales I: Recent advances in the
management of peptic ulcer bleeding. F1000Res. 6:17632017.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Scott JH, Gordon M, Vender R, Pettigrew S,
Desai P, Marchetti N, Mamary AJ, Panaro J, Cohen G, Bashir R, et
al: Venoarterial extracorporeal membrane oxygenation in massive
pulmonary embolism-related cardiac arrest: A systematic review.
Crit Care Med. 49:760–769. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Vanden Hoek TL, Morrison LJ, Shuster M,
Donnino M, Sinz E, Lavonas EJ, Jeejeebhoy FM and Gabrielli A: Part
12: Cardiac arrest in special situations: 2010 American Heart
Association guidelines for cardiopulmonary resuscitation and
emergency cardiovascular care. Circulation. 122
(18_suppl_3):S829–S861. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Amacher SA, Bohren C, Blatter R, Becker C,
Beck K, Mueller J, Loretz N, Gross S, Tisljar K, Sutter R, et al:
Long-term survival after out-of-hospital cardiac arrest: A
systematic review and meta-analysis. JAMA Cardiol. 7:633–643. 2022.
View Article : Google Scholar
|
|
90
|
Cho Y, Oh J, Shin JH, Kim BS, Park JK, Lee
JH, Kim JH and Park M: Long-term prognosis and causes of death
among survivors after out-of-hospital cardiac arrest: A
population-based longitudinal study. Resuscitation. 173:31–38.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Chocron R, Fahrenbruch C, Yin L, Guan S,
Drucker C, Shin J, Eisenberg M, Chatterjee NA, Kudenchuk PJ and Rea
T: Association between functional status at hospital discharge and
long-term survival after out-of-hospital-cardiac-arrest.
Resuscitation. 164:30–37. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Berg KM, Soar J, Andersen LW, Böttiger BW,
Cacciola S, Callaway CW, Couper K, Cronberg T, D'Arrigo S, Deakin
CD, et al: Adult advanced life support: 2020 international
consensus on cardiopulmonary resuscitation and emergency
cardiovascular care science with treatment recommendations.
Circulation. 142 (16_suppl_1):S92–S139. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Maconochie IK, Aickin R, Hazinski MF,
Atkins DL, Bingham R, Couto TB, Guerguerian AM, Nadkarni VM, Ng KC,
Nuthall GA, et al: Pediatric life support 2020 international
consensus on cardiopulmonary resuscitation and emergency
cardiovascular care science with treatment recommendations.
Pediatrics. 147 (Suppl 1):e2020038505B2021. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Kireyev D, Tan HC and Poh KK: Management
of acute ST-elevation myocardial infarction: Reperfusion options.
Ann Acad Med Singap. 39:927–933. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Pinto DS, Frederick PD, Chakrabarti AK,
Kirtane AJ, Ullman E, Dejam A, Miller DP, Henry TD and Gibson CM;
National Registry of Myocardial Infarction Investigators, : Benefit
of transferring ST-segment-elevation myocardial infarction patients
for percutaneous coronary intervention compared with administration
of onsite fibrinolytic declines as delays increase. Circulation.
124:2512–2521. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Böttiger BW and Martin E: Thrombolytic
therapy during cardiopulmonary resuscitation and the role of
coagulation activation after cardiac arrest. Curr Opin Crit Care.
7:176–183. 2001.
|
|
97
|
Böttiger BW, Arntz HR, Chamberlain DA,
Bluhmki E, Belmans A, Danays T, Carli PA, Adgey JA, Bode C, Wenzel
V, et al: Thrombolysis during resuscitation for out-of-hospital
cardiac arrest. N Engl J Med. 359:2651–2662. 2008. View Article : Google Scholar
|
|
98
|
Higgins JP and Altman DG: Assessing risk
of bias in included studies. Cochrane handbook for systematic
reviews of interventions: Cochrane Book Series. 2008:187–241. 2008.
View Article : Google Scholar
|
|
99
|
Vedantham S, Piazza G, Sista AK and
Goldenberg NA: Guidance for the use of thrombolytic therapy for the
treatment of venous thromboembolism. J Thromb Thrombolysis.
41:68–80. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Luchini C, Veronese N, Nottegar A, Shin
JI, Gentile G, Granziol U, Soysal P, Alexinschi O, Smith L and
Solmi M: Assessing the quality of studies in meta-research:
Review/guidelines on the most important quality assessment tools.
Pharm Stat. 20:185–195. 2021. View Article : Google Scholar
|
|
101
|
Zhou Y, Yan S, Song X, Gong Y, Li W, Wang
M, Yin X, Hu B and Lu Z: Intravenous thrombolytic therapy for acute
ischemic stroke in Hubei, China: A survey of thrombolysis rate and
barriers. BMC Neurol. 19:1–9. 2019. View Article : Google Scholar
|
|
102
|
Berger AK, Radford MJ, Wang Y and Krumholz
HM: Thrombolytic therapy in older patients. J Am Coll Cardiol.
36:366–374. 2000. View Article : Google Scholar
|
|
103
|
Sølling C, Ashkanian M, Hjort N,
Gyldensted C, Andersen G and Østergaard L: Feasibility and
logistics of MRI before thrombolytic treatment. Acta Neurol Scand.
120:143–149. 2009. View Article : Google Scholar
|
|
104
|
Thortveit ET, Bøe MG, Ljøstad U, Mygland Å
and Tveiten A: Organizational changes aiming to reduce iv tPA
door-to-needle time. Acta Neurol Scand. 130:248–252. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Salehi M, Kamali MJ, Rajabzadeh A, Minoo
S, Mosharafi H, Saeedi F and Daraei A: tRNA-derived fragments: Key
determinants of cancer metastasis with emerging therapeutic and
diagnostic potentials. Arch Biochem Biophys. 753:1099302024.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Ma H, Jiang Z, Xu J, Liu J and Guo ZN:
Targeted nano-delivery strategies for facilitating thrombolysis
treatment in ischemic stroke. Drug Deliv. 28:357–371. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Zamanlu M, Farhoudi M, Eskandani M,
Mahmoudi J, Barar J, Rafi M and Omidi Y: Recent advances in
targeted delivery of tissue plasminogen activator for enhanced
thrombolysis in ischaemic stroke. J Drug Target. 26:95–109. 2018.
View Article : Google Scholar
|
|
108
|
Yang Y, Chang Q, Chen J, Zou X, Xue Q and
Song A: Application of integrated emergency care model based on
failure modes and effects analysis in patients with ischemic
stroke. Front Surg. 9:8745772022. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Taccone FS, Nobile L and Annoni F:
Thrombolysis for ECMO oxygenator thrombosis. Crit Care. 27:1422023.
View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Reisinger AC, Fandler-Höfler S, Kreuzer P,
Toth-Gayor G, Schmidt A, Gary T, Rief P, Eller P and Brodmann M:
VA-ECMO and thrombus aspiration in a pulmonary embolism patient
with cardiac arrest and contraindications to thrombolytic therapy.
Vasa. 51:315–319. 2022. View Article : Google Scholar
|
|
111
|
Lin TW, Tsai MT, Hu YN, Wang YC, Wen JS,
Wu HY, Luo CY and Roan JN: Simultaneous thrombolysis and
extracorporeal membrane oxygenation for acute massive pulmonary
emboli. Ann Thorac Surg. 111:923–929. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Han TS, Gulli G, Fry CH, Affley B, Robin
J, Fluck D, Kakar P and Sharma P: Adverse consequences of immediate
thrombolysis-related complications: A multi-centre registry-based
cohort study of acute stroke. J Thromb Thrombolysis. 53:1–10. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Zonjee VJ, Slenders JP, de Beer F, Visser
MC, Ter Meulen BC, Van den Berg-Vos RM and van Schaik SM: Practice
variation in the informed consent procedure for thrombolysis in
acute ischemic stroke: A survey among neurologists and neurology
residents. BMC Med Ethics. 22:1–9. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Szalados JE: The ethics and laws governing
informed decision-making in healthcare: Informed consent, refusal,
and discussions regarding resuscitation and life-sustaining
treatment. The medical-legal aspects of acute care medicine: A
resource for clinicians, administrators, and risk managers.
Springer; 2021, pp. 43–73. View Article : Google Scholar
|
|
115
|
Milling L, Binderup LG, de Muckadell CS,
Christensen EF, Lassen A, Christensen HC, Nielsen DC and Mikkelsen
S; The Danish Cardiac Arrest Registry Group, : Documentation of
ethically relevant information in out-of-hospital resuscitation is
rare: A Danish nationwide observational study of 16,495
out-of-hospital cardiac arrests. BMC Med Ethics. 22:822021.
View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Zenych A, Fournier L and Chauvierre C:
Nanomedicine progress in thrombolytic therapy. Biomaterials.
258:1202972020. View Article : Google Scholar : PubMed/NCBI
|
